PINK:COEP

Coeptis Therapeutics Stock Predictions

etoro logo Buy COEP
*Your capital is at risk
$16.40
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

COEP Prediction Chart

COEP Predictions History

Latest community submissions for COEP.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 22, 2025 $13.57 -2.20% $15.74 X 86.24% 0
Sep 22, 2025 $13.69 -1.37% $15.74 X 86.97% 0
Sep 22, 2025 Bullish $15.74 V 1
Aug 25, 2025 $13.83 +2.72% $13.66 V 98.75% 2
Aug 25, 2025 $13.23 -1.70% $13.66 X 96.90% 0
Aug 25, 2025 $24.40 +81.68% $13.66 V 21.31% 1
Aug 11, 2025 $10.97 -1.72% $11.06 V 99.17% 3
Aug 11, 2025 $12.50 +12.01% $11.06 X 86.98% 0
Feb 7, 2025 $11.49 +6.61% $11.71 V 98.14% 1
Feb 7, 2025 $11.23 +4.13% $11.71 V 95.86% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for COEP with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COEPTIS THERAPEUTICS INC.
Coeptis Therapeutics
Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the abilit...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE